Protein formulations Flashcards
Problems with protein delivery
Large hydrophilic molecules
Extra-vascular access difficult
Poor stability
Purity of recombinant products
Complex pharmacological action
Barriers to protein drug delivery
LMW drugs reach sites of action by diffusion + partition
HMW + hydrophilic drugs, anatomy + physiology present many barriers
Size + shape of macromolecule + proteins
Relationships between Mw + size depends on shape
- e.g. polysaccharides, branching, loose random, coils
- Proteins = globular + tightly packed; smaller than same Mw polsaccharides
Bigger the Mw, bigger the size (nm)
IgM = large; acts as small particle
- o transit through basement membrane + little extravasation
Factors determining biodistribution of macromolecules
Ability of macromolecules to be transported across endothelium
Differences in relative blood flow to different tissues
Amount reaching tissues also affected by rate of elimination by kidneys + metabolism
How are macromolecules eliminated?
Small proteins, oligonucleotides = kidney (by glomerular filtration)
- Larger macromolecules are not eliminated by kidney filtration
Cut-off for glomerular filtration
- 60kDa - proteins
- 40kDa - dextrans (polysaccharides)
Metabolism of macromolecules
Removing old serum proteins + unwanted macromolecules (by dying cells) mainly by receptors on parenchymal cells + macrophages
e.g. Asialoglycoprotein (ASGPR)
Sugars below terminal sugar residue, sialic acid, are recognised by specific receptors when terminal sugar is cleaved off
ASGPR recognises D-galactose
Materials cleared by ASGP receptor
Hormones
Carrier molecules
Protease inhibitors
Immunological
- Other receptors = N-Acetylgalactosamine recetor on macrophages + fucose receptor on liver parenchymal cells*
- Other proteins e.g. albumin + LDL have no sugar residue. These proteins age + are acetylated + cleared by a receptor recognising acetylated proteines*
- There is a receptor that removes unwanted DNA from circulation*
How are macromolecules cleared + metabolised?
After binding to receptor, proteins endocystose + sent to lysosomes
Macromolecules are regulated + metabolised by the liver
Importance of clearance receptors to drug delivery?
Protein drugs cleared from circulation using normal homeostatic mechanism
Specific receptors used to target drugs to liver
Cytotoxic drugs could cause liver toxicity
Propterties of protein + peptide drugs
Large, hydrophilic molecules
Not well transported across biological membranes (<2& bioavailability)
Physical, chemical + biological instabilities
Major disadvantages compared with small MW drugs
Physical stability of proteins
Proteins lose native 3D structure
Unfolding/denaturation due to:
- hydrophobic conditions, surfactants
- pH, solvent, temperature
- dehydration, lyophilisation
Adsorption
- polar + non-polar residues
- Adsorbed + interfaces
- aire-water-foaming
- air-solid
Aggregation
- denatured, unfolded proteins may interact
- Aggregation becomes precipitation @ macroscopic level
Routes of admin.
How to improve oral bioavailability of proteins/peptides
Potential adverse effects of inhaled insulin
Inhaled insulin pharmacokinetics/dynamics